Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of escitalopram on sleep architecture
utilizing a prospective design.
Hypothesis: Escitalopram will improve REM latency in patients with MDD that have responded
clinically to treatment.